Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Carregando...
Citações na Scopus
561
Tipo de produção
article
Data de publicação
2018
Editora
CELL PRESS
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
KAHLES, Andre
LEHMANN, Kjong-Van
TOUSSAINT, Nora C.
HUSER, Matthias
STARK, Stefan G.
SACHSENBERG, Timo
STEGLE, Oliver
KOHLBACHER, Oliver
SANDER, Chris
RATSCH, Gunnar
Autor de Grupo de pesquisa
Canc Genome Atlas Res Network
Editores
Coordenadores
Organizadores
Citação
CANCER CELL, v.34, n.2, p.211-224.e6, 2018
Resumo
Our comprehensive analysis of alternative splicing across 32 The Cancer Genome Atlas cancer types from 8,705 patients detects alternative splicing events and tumor variants by reanalyzing RNA and whole-exome sequencing data. Tumors have up to 30% more alternative splicing events than normal samples. Association analysis of somatic variants with alternative splicing events confirmed known trans associations with variants in SF3B1 and U2AF1 and identified additional trans-acting variants (e.g., TADA1, PPP2R1A). Many tumors have thousands of alternative splicing events not detectable in normal samples; on average, we identified approximate to 930 exon-exon junctions (""neojunctions'') in tumors not typically found in GTEx normals. From Clinical Proteomic Tumor Analysis Consortium data available for breast and ovarian tumor samples, we confirmed approximate to 1.7 neojunction- and approximate to 0.6 single nucleotide variant-derived peptides per tumor sample that are also predicted major histocompatibility complex-I binders (""putative neoantigens'').
Palavras-chave
Referências
- Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492
- Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
- Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615
- Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
- Barrett CL, 2015, P NATL ACAD SCI USA, V112, pE3050, DOI 10.1073/pnas.1508057112
- Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404
- Bjorklund SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05537-0
- Blum A, 2018, CELL, V173, P530, DOI 10.1016/j.cell.2018.03.059
- Brooks AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087361
- Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
- Celebi JT, 2000, HUM GENET, V107, P234
- Chen HJ, 2017, HUM MUTAT, V38, P1372, DOI 10.1002/humu.23288
- Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385
- Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038
- Climente-Gonzalez H, 2017, CELL REP, V20, P2215, DOI 10.1016/j.celrep.2017.08.012
- Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107
- David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697
- Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
- Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
- Edwards NJ, 2015, J PROTEOME RES, V14, P2707, DOI 10.1021/pr501254j
- Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002
- Fonseca N.A., 2017, BIORXIV, DOI [10.1101/183889, DOI 10.1101/183889]
- Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285
- Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330
- Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046
- Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717
- Gong J, 2018, NUCLEIC ACIDS RES, V46, pD971, DOI 10.1093/nar/gkx861
- Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031
- Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610
- Hatje K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177728
- Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049
- Kahles A, 2016, BIOINFORMATICS, V32, P1840, DOI 10.1093/bioinformatics/btw076
- Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299
- Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046
- LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259
- Lehmann Kjong-Van, 2015, Pac Symp Biocomput, P44
- Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
- Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034
- Li Y, 2017, CANCER LETT, V393, P40, DOI 10.1016/j.canlet.2017.02.016
- Lippert C., 2014, BIORXIV, DOI [10.1101/003905, DOI 10.1101/003905]
- McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
- Meliso FM, 2017, HUM GENET, V136, P1129, DOI 10.1007/s00439-017-1819-2
- Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003
- Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
- Nellore A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1118-6
- Okumura N, 2011, BIOCHEM BIOPH RES CO, V413, P395, DOI 10.1016/j.bbrc.2011.08.098
- Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467
- Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001
- Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
- Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236
- Robertson AG, 2018, CANCER CELL, V33, P151, DOI 10.1016/j.ccell.2017.12.013
- Rost HL, 2016, NAT METHODS, V13, P741, DOI [10.1038/NMETH.3959, 10.1038/nmeth.3959]
- Rossi D, 2011, BLOOD, V118, P6904, DOI 10.1182/blood-2011-08-373159
- Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004
- Saha A, 2017, GENOME RES, V27, P1843, DOI 10.1101/gr.216721.116
- Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005
- Schafer Sebastian, 2015, Curr Protoc Hum Genet, V87, DOI 10.1002/0471142905.hg1116s87
- Sebestyen E, 2015, NUCLEIC ACIDS RES, V43, P1345, DOI 10.1093/nar/gku1392
- Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344
- Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053
- Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055
- Sun ZC, 2017, CANCER LETT, V392, P17, DOI 10.1016/j.canlet.2016.12.039
- Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI 10.1002/0471250953.bi1110s43
- van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
- Vauchy C, 2015, INT J CANCER, V137, P116, DOI 10.1002/ijc.29366
- Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608
- Vitiello A, 2017, NAT BIOTECHNOL, V35, P815, DOI 10.1038/nbt.3932
- Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
- Wang XJ, 2018, MOL CELL PROTEOMICS, V17, P422, DOI 10.1074/mcp.RA117.000155
- Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010
- Wilks C., 2013, P AS PAC ADV NETW, V35, DOI [10.7125/APAN.35.1, DOI 10.7125/APAN.35.1]
- Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
- Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444
- Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069
- Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220
- Zhu JY, 2018, GYNECOL ONCOL, V148, P368, DOI 10.1016/j.ygyno.2017.11.028